Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
A step-by-step guide to performing cancer metabolism research using custom-made media.
Journal: Life science alliance
Published: October 10, 2025
Replication-associated base excision repair/single-strand break repair regulates PARG inhibitor response via the PRMT1/PRMT5/ATR axis.
Journal: NAR cancer
Published: August 19, 2025
Effects of current smoking on treatment outcomes in metastatic and locally advanced pancreatic carcinoma: a retrospective cohort study using the international PURPLE pancreas cancer registry.
Journal: Journal of gastrointestinal oncology
Published: March 09, 2025
NAD+ Boosting Through NRH Supplementation Enhances Treatment Efficacy in EOC In Vitro.
Journal: International journal of molecular sciences
Published: January 21, 2025
Therapeutic potential of dihydronicotinamide riboside (NRH) on obesity and glucose intolerance in mice.
Journal: Nature communications
Published: August 20, 2024
Examining drinking water quality: analysis of physico-chemical properties and bacterial contamination with health implications for Shangla district, Khyber Pakhtunkhwa, Pakistan.
Journal: Environmental geochemistry and health
Published: January 25, 2024
Synthesis, Detection, and Metabolism of Pyridone Ribosides, Products of NAD Overoxidation.
Journal: Chemical research in toxicology
Published: January 10, 2024
Targeting the autophagy-NAD axis protects against cell death in Niemann-Pick type C1 disease models.
Targeting the autophagy-NAD axis protects against cell death in Niemann-Pick type C1 disease models.
Journal: Cell death & disease
Published: November 16, 2023
Oncometabolite 2-hydroxyglutarate suppresses basal protein levels of DNA polymerase beta that enhances alkylating agent and PARG inhibition induced cytotoxicity.
Journal: DNA repair
Published: March 10, 2023
Nicotinamide Riboside and Dihydronicotinic Acid Riboside Synergistically Increase Intracellular NAD+ by Generating Dihydronicotinamide Riboside.
Journal: Nutrients
Published: June 15, 2022
Overcoming Temozolomide Resistance in Glioblastoma via Enhanced NAD+ Bioavailability and Inhibition of Poly-ADP-Ribose Glycohydrolase.
Journal: Cancers
Published: June 14, 2022
Last Updated: 09/26/2026